Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Archives of Virology
Published in: Archives of Virology 11/2013

01-11-2013 | Original Article

Antigenic and genetic analyses of isolate APMV/wigeon/Italy/3920-1/2005 indicate that it represents a new avian paramyxovirus (APMV-12)

Authors: C. Terregino, E. W. Aldous, A. Heidari, C. M. Fuller, R. De Nardi, R. J. Manvell, M. S. Beato, W. M. Shell, I. Monne, I. H. Brown, D. J. Alexander, I. Capua

Published in: Archives of Virology | Issue 11/2013

Login to get access

Abstract

Isolate wigeon/Italy/3920-1/2005 (3920-1) was obtained during surveillance of wild birds in November 2005 in the Rovigo province of Northern Italy and shown to be a paramyxovirus. Analysis of cross-haemagglutination-inhibition tests between 3920-1 and representative avian paramyxoviruses showed only a low-level relationship to APMV-1. Phylogenetic analysis of the whole genome and each of the six genes indicated that while 3920-1 grouped with APMV-1 and APMV-9 viruses, it was quite distinct from these two. In the whole-genome analysis, 3920-1 had 52.1 % nucleotide sequence identity to the closest APMV-1 virus, 50.1 % identity to the APMV-9 genome, and less than 42 % identity to representatives of the other avian paramyxovirus groups. We propose isolate wigeon/Italy/3920-1/2005 as the prototype strain of a further APMV group, APMV-12.
Literature
1.
Alamares JG, Li J, Iorio RM (2005) Monoclonal antibody routinely used to identify avirulent strains of Newcastle disease virus binds to an epitope at the carboxy terminus of the hemagglutinin-neuraminidase protein and recognizes individual mesogenic and velogenic strains. J Clin Microbiol 43:4229–4233PubMedCrossRef
2.
Aldous EW, Mynn JK, Banks J, Alexander DJ (2003) A molecular epidemiological study of avian paramyxovirus type 1 (Newcastle disease virus) isolates by phylogenetic analysis of a partial nucleotide sequence of the fusion protein gene. Avian Pathol 32:239–357PubMedCrossRef
3.
Alexander DJ (1993) Paramyxovirus infections. In: McFerran JB, McNulty MS (eds) Viral infections of vertebrates. Viral infections of birds, vol 3. Elsevier, Amsterdam, pp 321–340
4.
Alexander DJ, Hinshaw VS, Collins MS, Yamane N (1983) Characterisation of viruses which represent further distinct serotypes (PMV-8 and PMV-9) of avian paramyxoviruses. Arch Virol 78:29–36PubMedCrossRef
5.
Anderson C, Kearsley R, Alexander DJ, Russell PH (1987) Antigenic variation in avian paramyxovirus type 3 isolates detected by mouse monoclonal antibodies. Avian Pathol 16:691–698PubMedCrossRef
6.
Archetti I, Horsfall FL (1951) Persistent antigenic variation of influenza A viruses after incomplete neutralization in ovo with heterologous immune serum. J Exp Med 92:441–462CrossRef
7.
8.
Chang PC, Hsieh ML, Shien JH, Graham DA, Lee MS, Shieh HK (2001) Complete nucleotide sequence of avian paramyxovirus type 6 isolated from ducks. J Gen Virol 82:2157–2168PubMed
9.
Cho SH, Kwon HJ, Kim TE, Kim JH, Yoo HS, Kim SJ (2008) Variation of a Newcastle disease virus hemagglutinin-neuraminidase linear epitope. J Clin Microbiol 46:1541–1544PubMedCrossRef
10.
11.
Diel DG, da Silva LH, Liu H, Wang Z, Miller PJ, Afonso CL (2012) Genetic diversity of avian paramyxovirus type 1: proposal for a unified nomenclature and classification system of Newcastle disease virus genotypes. Infect Genet Evol 12(8):1770–1779PubMedCrossRef
12.
Doane FW, Anderson N (1987) Electron microscopy in diagnostic virology: a practical guide and atlas. Cambridge University Press, Cambridge, p 181
13.
Felsenstein J (1985) Confidence limits on phylogenies: an approach using the bootstrap. Evolution 39:783–791CrossRef
14.
Hasegawa M, Kishino H, Yano T (1985) Dating the human–ape split by a molecular clock of mitochondrial DNA. J Mol Evol 22:160–174PubMedCrossRef
15.
Hu S, Wang T, Liu Y, Meng C, Wang X, Wu Y, Liu X (2010) Identification of a variable epitope on the Newcastle disease virus hemagglutinin-neuraminidase protein. Vet Microbiol 140:92–97PubMedCrossRef
16.
Kumar S, Nayak B, Collins PL, Samal SK (2008) Complete genome sequence of avian paramyxovirus type 3 reveals an unusually long trailer region. Virus Res 137:189–197PubMedCrossRef
17.
Lamb R, Parks GD (2007) Paramyxoviridae: the viruses and their replication. In: Fields B, Knipe DM, Howley PM (eds) Virology, vol 1. Lippincott, Williams and Wilkins, Philadelphia, pp 1449–1496
18.
Miller PJ, Afonso CL, Spackman E, Scott MA, Pedersen JC, Senne DA, Brown JD, Fuller CM, Uhart MM, Karesh WB, Brown IH, Alexander DJ, Swayne DE (2010) Evidence for a new avian paramyxovirus serotype 10 detected in rockhopper penguins from the Falkland Islands. J Virol 84:11496–11504PubMedCrossRef
19.
Nayak B, Kumar S, Collins PL, Samal SK (2008) Molecular characterization and complete genome sequence of avian paramyxovirus type 4 prototype strain duck/Hong Kong/D3/75. Virol J 5:124PubMedCrossRef
20.
Paldurai A, Subbiah M, Kumar S, Collins PL, Samal SK (2009) Complete genome sequences of avian paramyxovirus type 8 strains goose/Delaware/1053/76 and pintail/Wakuya/20/78. Virus Res 142:144–153PubMedCrossRef
21.
Samuel AS, Kumar S, Madhuri S, Collins PL, Samal SK (2009) Complete sequence of the genome of avian paramyxovirus type 9 and comparison with other paramyxoviruses. Virus Res 142:10–18PubMedCrossRef
22.
23.
Subbiah M, Xioa S, Collins PL, Samal SK (2008) Complete sequence of the genome of avian paramyxovirus type 2 (strain Yucaipa) and comparison with other paramyxoviruses. Virus Res 137:40–48PubMedCrossRef
24.
Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S (2011) MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 28:2731–2739PubMedCrossRef
25.
Tamura K, Nei M (1993) Estimation of the number of nucleotide substitutions in the control region of mitochondrial DNA in humans and chimpanzees. Mol Biol Evol 10:512–526PubMed
26.
Toyoda T, Gotoh B, Sakaguchi T, Kida H, Nagai Y (1988) Identification of amino acids relevant to three antigenic determinants on the fusion protein of Newcastle disease virus that are involved in fusion inhibition and neutralization. J Virol 62:4427–4430PubMed
27.
World Organisation for Animal Health (OIE) (2008) Newcastle disease. Chapter 2.3.14 manual of diagnostic tests and vaccines for terrestrial animals, 6th edn. OIE, Paris, pp 576–589
28.
Xiao S, Paldurai A, Nayak B, Subbiah M, Collins PL, Samal SK (2009) Complete genome sequence of avian paramyxovirus type 7 (strain Tennessee) and comparison with other paramyxoviruses. Virus Res 145:80–91PubMedCrossRef
29.
Zhao Y, Hammond RW (2005) Development of a candidate vaccine for Newcastle disease virus by epitope display in the cucumber mosaic virus capsid protein. Biotechnol Lett 27:375–382PubMedCrossRef
Metadata
Title
Antigenic and genetic analyses of isolate APMV/wigeon/Italy/3920-1/2005 indicate that it represents a new avian paramyxovirus (APMV-12)
Authors
C. Terregino
E. W. Aldous
A. Heidari
C. M. Fuller
R. De Nardi
R. J. Manvell
M. S. Beato
W. M. Shell
I. Monne
I. H. Brown
D. J. Alexander
I. Capua
Publication date
01-11-2013
Publisher
Springer Vienna
Published in
Archives of Virology / Issue 11/2013
Print ISSN: 0304-8608
Electronic ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-013-1735-2

Other articles of this Issue 11/2013

Archives of Virology 11/2013 Go to the issue

Annotated Sequence Record

Complete genome sequence of a polyvalent bacteriophage, phiKP26, active on Salmonella and Escherichia coli

Annotated Sequence Record

Genomic organization of a novel partitivirus from the phytopathogenic fungus Ustilaginoidea virens

Brief Report

Genotyping and subtyping of mumps virus isolates from the Indian subcontinent

Original Article

Clinical and molecular epidemiology of norovirus infection in adults with acute gastroenteritis in Ji’nan, China

Original Article

Isolation and characterization of phages with lytic activity against methicillin-resistant Staphylococcus aureus strains belonging to clonal complex 398

Original Article

Lymphoma outbreak in a GASH:Sal hamster colony
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits